Location: Home
  • search
  • go
  • Relate News
  • 9/11/2018SMIA’s Official Responsibilities and Internal Organization Approved
  • 9/11/2018NMPA's Official Responsibilities and Internal Organization Approved
  • 9/11/2018SAMR's Official Responsibilities and Internal Organization Approved
  • 9/11/2018WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manu...
  • 9/11/2018Innovent Receives Chinese IND Approval for mAb Drug Candidate
  • 9/11/2018China CDMO Market 2018-2021: The R&D Cost of New Drugs Continues t...
  • 9/10/2018NMPA Issues New Announcement (2018#64) for Clinical Data Self-Inspecti...
  • 9/7/2018Recent Executive Moves
  • 9/7/2018Nearly 90% of Listed Biopharma Cos Saw their Sales Expenditures Up in ...
  • 9/7/2018Astellas Launches Its OAB Drug Myrbetriq (mirabegron) in China
  • 9/7/2018NMPA Withdraws Approvals of Six Drugs Including Four Import Drugs
  • 9/6/2018Eisai and MSD Announce NMPA Approval of HCC Drug LENVIMA
  • 9/5/2018NMPA Approves Alexion's Orphan Drug Soliris (Eculizumab)
  • 9/5/2018Chi-Med Announces Chinese Approval of CRC Drug Fruquintinib
  • 9/5/2018Minomic Secures Key Patent in the U.S. and China
  • 9/4/2018IQVIA: Chinese Hospital Drug Market Up 3.7% in MAT Q1/2018
  • 9/3/2018Listed Chinese Healthcare Cos Witness Best Performance in Nine Years
  • 8/31/2018Recent Executive Moves
  • 8/31/2018Financial-related Company News in Brief
  • 8/30/2018Final Government Reorganization Plan Unveils Regulatory Roles of SAMR ...
  • 8/30/2018New English Name of China's Drug Watchdog Confirmed to be NMPA
  • 8/30/2018NYT: China Withholds H7N9 Bird Flu Sample
  • 8/29/2018State Council Issues Notice for Major Tasks of Healthcare Reform in H2...
  • 8/29/2018CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China
  • 8/29/2018Bloomburg: Wall Street Expats Angle for Piece of China’s Biotech Drug...
  • 8/28/2018Premier Li Keqiang Orders Reinforced Healthcare Reform
  • 8/28/2018I-Mab Approved to Initiate Clinical Study of Genexine’s Diabetes Drug
  • 8/28/2018China Biologic Turns Down Buyout Proposal from CEO-led Consortium
  • 8/27/2018Harbour BioMed Raises $85M in Series B Financing to Accelerate Its Inn...
  • 8/27/2018FT: China Health Reforms Help Global Pharma Groups Despite Price Cuts?
  • Page:156/357 Total number of articles:10698: [First][<<] [154] [155] [156] [157] [158] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group